Diagnostic Approach to Gastrinoma

Introduction to Gastrinoma Diagnosis

The National Comprehensive Cancer Network recommends measuring fasting serum gastrin after discontinuing proton pump inhibitors for at least 1 week, as a primary diagnostic test for gastrinoma 3
A combination of fasting serum gastrin >10 times elevated AND gastric pH <2 is diagnostic of gastrinoma, according to the National Comprehensive Cancer Network 3

The American College of Gastroenterology and the National Comprehensive Cancer Network suggest that chromogranin A (CgA) is elevated in only 60% of neuroendocrine tumors overall, meaning 40% have normal levels despite active disease 1, 2
Proton pump inhibitors cause spurious CgA elevation through increased gastrin secretion and subsequent ECL cell stimulation, as noted by the National Comprehensive Cancer Network and Praxis Medical Insights 3, 1
Renal failure, liver failure, hypertension, and chronic gastritis all cause false CgA elevation, according to the National Comprehensive Cancer Network and Praxis Medical Insights 3, 1, 2

When evaluating suspected gastrinoma, stop proton pump inhibitors for 1-2 weeks before any biochemical testing, as recommended by the National Comprehensive Cancer Network and Praxis Medical Insights 3, 4
Measure fasting serum gastrin and gastric pH as the primary diagnostic tests, according to the National Comprehensive Cancer Network 3
Obtain multiphasic CT or MRI for tumor localization, as suggested by the National Comprehensive Cancer Network and Praxis Medical Insights 3, 1
Consider CgA only as a category 3 (optional) test that may help with prognosis if elevated, but do not rely on it for diagnosis, as recommended by the National Comprehensive Cancer Network and Praxis Medical Insights 3, 1